Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_assertion type Assertion NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_head.
- NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_assertion description "[Our results indicate that targeting HER-2 with T-DM1 may offer a new therapeutic approach in HER-2 over-expressing lung cancers including those resistant to EGFR TKIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_provenance.
- NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_assertion evidence source_evidence_literature NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_provenance.
- NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_assertion SIO_000772 24898067 NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_provenance.
- NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_assertion wasDerivedFrom befree-20150227 NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_provenance.
- NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_assertion wasGeneratedBy ECO_0000203 NP379527.RAVyRP2uBRhE3Hq0uxTOh132F8EeY88NPzg7JaLEHoR1U130_provenance.